cytarabine has been researched along with bisbenzimidazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, W; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Illmer, C; Krupitza, G; Mader, RM; Madlener, S; Saiko, P; Schott, H; Szekeres, T | 1 |
Erker, T; Fritzer-Szekeres, M; Handler, N; Horvath, Z; Jaeger, W; Murias, M; Saiko, P; Szekeres, T | 1 |
2 other study(ies) available for cytarabine and bisbenzimidazole
Article | Year |
---|---|
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; Coloring Agents; Cytarabine; Dimerization; Dinucleoside Phosphates; Fluorescent Dyes; Fluorouracil; Humans; Inhibitory Concentration 50; Lymphoma; Propidium | 2004 |
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bisbenzimidazole; Cell Cycle; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fluorescent Dyes; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Propidium; Pyrogallol; Stilbenes | 2006 |